|
|
|
|
| Symbol(s): |
TRBN |
| Date: |
7-Feb-10 |
| Contributor: |
PriceTarget Research, Inc. |
| Title: |
TRBN has a current Overall Rating of C (Neutral). |
| Document Size: |
7 pages |
| Price: |
$25 |
| Document Type: |
Adobe Acrobat Reader®
Download free Adobe Acrobat Reader® |
|
| Research Reports Premium Services |
| ·
|
Get the full report for $25. |
| ·
|
You will have access to this report for 24 hours. |
|
|
|
|
|
| TRBN has a current Overall Rating of C (Neutral). Power Rating (73) is high; appreciation potential (13) is negative. Relative to the S&P 500 Composite, Trubion Pharmaceuticals Inc has moderate Value characteristics -- its appeal is likely to be to Capital Gain-oriented investors. TRBN is of low investment quality. TRBN's current technical position is mixed. TRBN's Power Rating is 73. The recent trend in TRBN's earnings estimates has been favorable. TRBN's Biological Products,...
| | |
|
|
